162 related articles for article (PubMed ID: 2706326)
1. Prognostic value of nuclear DNA content in breast cancer in relation to tumor size, nodal status, and estrogen receptor content.
von Rosen A; Rutqvist LE; Carstensen J; Fallenius A; Skoog L; Auer G
Breast Cancer Res Treat; 1989 Jan; 13(1):23-32. PubMed ID: 2706326
[TBL] [Abstract][Full Text] [Related]
2. DNA distribution, cytosol estrogen receptors and axillary nodes as prognostic predictors in breast carcinoma.
Klintenberg C; Wallgren A; Bjelkenkrantz K; Carstenssen J; Humla S; Nordenskjöld B; Skoog L
Acta Radiol Oncol; 1985; 24(3):253-8. PubMed ID: 2994376
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading.
Parl FF; Schmidt BP; Dupont WD; Wagner RK
Cancer; 1984 Nov; 54(10):2237-42. PubMed ID: 6488142
[TBL] [Abstract][Full Text] [Related]
4. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
Meyer JS; Province MA
Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
[TBL] [Abstract][Full Text] [Related]
5. Nuclear DNA content and prognosis in human breast cancer: a static cytophotometric study.
Harvey J; de Klerk N; Berryman I; Sterrett G; Byrne M; Papadimitriou J
Breast Cancer Res Treat; 1987; 9(2):101-9. PubMed ID: 3304476
[TBL] [Abstract][Full Text] [Related]
6. Proliferative index, cytosol estrogen receptor and axillary node status as prognostic predictors in human mammary carcinoma.
Klintenberg C; Stål O; Nordenskjöld B; Wallgren A; Arvidsson S; Skoog L
Breast Cancer Res Treat; 1986; 7 Suppl():S99-106. PubMed ID: 3742067
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patients.
Gasparini G; Toi M; Verderio P; Ranieri G; Dante S; Bonoldi E; Boracchi P; Fanelli M; Tominaga T
Int J Oncol; 1998 May; 12(5):1117-25. PubMed ID: 9538138
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in locally advanced breast cancer (T3, T4) with special reference to tumor cell DNA content.
Arnerlöv C; Emdin SO; Roos G; Angström T; Bjersing L; Angquist KA; Larsson LG; Jonsson H
Acta Oncol; 1988; 27(3):221-6. PubMed ID: 3415850
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor status as a prognostic indicator for stage I breast cancer patients.
Crowe JP; Hubay CA; Pearson OH; Marshall JS; Rosenblatt J; Mansour EG; Hermann RE; Jones JC; Flynn WJ; McGuire WL
Breast Cancer Res Treat; 1982; 2(2):171-6. PubMed ID: 7171837
[TBL] [Abstract][Full Text] [Related]
10. The relationship of estrogen receptor status to DNA ploidy in breast cancer.
Tsuchiya A; Nihei M; Ando Y; Suzuki S; Kimijima I; Abe R
Surg Today; 1992; 22(2):105-9. PubMed ID: 1498488
[TBL] [Abstract][Full Text] [Related]
11. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
Pinto AE; André S; Soares J
J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
[TBL] [Abstract][Full Text] [Related]
12. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
[TBL] [Abstract][Full Text] [Related]
13. Significance of axillary lymph node metastasis in primary breast cancer.
Jatoi I; Hilsenbeck SG; Clark GM; Osborne CK
J Clin Oncol; 1999 Aug; 17(8):2334-40. PubMed ID: 10561295
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancer.
Stål O; Wingren S; Carstensen J; Rutqvist LE; Skoog L; Klintenberg C; Nordenskjöld B
Eur J Cancer Clin Oncol; 1989 Feb; 25(2):301-9. PubMed ID: 2702984
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years.
Reed W; Hannisdal E; Boehler PJ; Gundersen S; Host H; Marthin J
Cancer; 2000 Feb; 88(4):804-13. PubMed ID: 10679650
[TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients.
Esteban JM; Felder B; Ahn C; Simpson JF; Battifora H; Shively JE
Cancer; 1994 Sep; 74(5):1575-83. PubMed ID: 7914825
[TBL] [Abstract][Full Text] [Related]
17. Preoperative values of CA 15-3 and CEA as prognostic factors in breast cancer: a multivariate analysis.
Cañizares F; Sola J; Pérez M; Tovar I; De Las Heras M; Salinas J; Peñafiel R; Martínez P
Tumour Biol; 2001; 22(5):273-81. PubMed ID: 11553856
[TBL] [Abstract][Full Text] [Related]
18. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
[TBL] [Abstract][Full Text] [Related]
19. p53 as an independent prognostic marker in lymph node-negative breast cancer patients.
Silvestrini R; Benini E; Daidone MG; Veneroni S; Boracchi P; Cappelletti V; Di Fronzo G; Veronesi U
J Natl Cancer Inst; 1993 Jun; 85(12):965-70. PubMed ID: 8496982
[TBL] [Abstract][Full Text] [Related]
20. The nuclear DNA content of human breast carcinoma. Associations with clinical stage, axillary lymph node status, estrogen receptor status and outcome.
Berryman IL; Harvey JM; Sterrett GF; Papadimitriou JM
Anal Quant Cytol Histol; 1987 Oct; 9(5):429-34. PubMed ID: 3675802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
